IR-MED's PressureSafe™ Device Launches Usability Study at Methodist

IR-MED Initiates Usability Study of PressureSafe™ at Methodist Healthcare

IR-MED Inc. is excited to announce that it has commenced a usability study for its innovative PressureSafe™ device at the renowned Methodist Healthcare. This study aims to improve the early detection of pressure injuries, a pressing healthcare challenge affecting millions of patients every year.

Understanding PressureSafe™ and Its Capabilities

The PressureSafe™ device, a breakthrough in medical technology, employs a non-invasive approach using infrared optical spectroscopy and an advanced AI-driven algorithm. This allows it to effectively detect pressure injuries early, regardless of the patient's skin tone. By utilizing infrared light to monitor changes in biomarkers just beneath the skin, PressureSafe™ provides a more accurate means of early detection compared to standard visual inspections.

Current Healthcare Challenges

Pressure injuries are a significant healthcare burden, resulting in an estimated $26.8 billion spent annually in the U.S. for prevention and treatment. Tragically, they contribute to approximately 60,000 deaths each year. Research indicates that individuals with darker skin tones are more than twice as likely to suffer from pressure injuries, revealing a crucial gap in current monitoring practices.

Study Design and Implementation

The usability study at Methodist Healthcare will enroll up to 104 participants, with a balanced representation of individuals with darker skin tones. Trained wound care specialists will utilize the PressureSafe™ device to assess its effectiveness. The study will evaluate the device's sensitivity and specificity in comparison to traditional visual assessments by healthcare professionals.

Expert Insights from Methodist Healthcare

Dr. Mary Lee Potter, a key figure in the study and Director of Professional Nursing Practice at Methodist Healthcare, emphasizes the importance of this research in improving patient outcomes. She expresses eagerness to see how PressureSafe™ will enhance the accuracy of detecting pressure injuries, ultimately leading to better care for patients.

Impact of Study's Findings

This initiative marks a significant milestone not just for IR-MED, but for the healthcare community seeking solutions for reducing pressure injuries. Dr. Yaniv Cohen, Co-Founder and Chief Science Officer of IR-MED, is enthusiastic about the partnership with Methodist Healthcare and believes that the study will demonstrate how PressureSafe™ can support healthcare professionals in their vital work.

Prior Success and Future Prospects

Previous trials of the PressureSafe™ device conducted in Israel yielded impressive results, with the device detecting pressure injuries with 92% sensitivity. These positive outcomes not only underscore the potential of PressureSafe™ but also set a strong foundation for its validation in the U.S. healthcare system.

About IR-MED and Its Innovative Solutions

IR-MED is at the forefront of developing technology that enables real-time, non-invasive analysis of biological markers in tissues. PressureSafe™ is the first product aimed at addressing the urgent need for effective methods to identify and manage pressure injuries among patients of all skin tones. With patents protecting its innovative technologies, IR-MED is poised to make a significant impact in the medical field.

Frequently Asked Questions

What is the main purpose of the PressureSafe™ usability study?

The study aims to evaluate the effectiveness of the PressureSafe™ device in early detection of pressure injuries across different skin tones, ultimately improving patient outcomes.

How does PressureSafe™ work?

PressureSafe™ uses infrared light and artificial intelligence to detect biomarkers just beneath the skin's surface, providing a non-invasive way to monitor early signs of pressure injuries.

Who is conducting the usability study?

The study is being conducted in collaboration with Methodist Healthcare, with leadership from Dr. Mary Lee Potter, who oversees nursing practices at the facility.

What are the expected results from this study?

IR-MED anticipates that the study will demonstrate the effectiveness of PressureSafe™ in detecting pressure injuries with high sensitivity, thus contributing to improved care for patients, especially those with darker skin tones.

What challenges does the healthcare community face regarding pressure injuries?

One of the key challenges is that individuals with darker skin tones are often missed by traditional visual assessments, leading to delayed care and worse outcomes. This study aims to bridge that gap.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.